Issues related to the America First Global Health Strategy, bilateral global health cooperation, and potential third-party clinical services support for U.S. global health assistance and partner-country health initiatives.
2026 · 2nd Quarter (Apr 1 - June 30)
BLUE GENES, LLC
Filed by ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC).
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 16, 2026
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC)
- Client
- BLUE GENES, LLC
- Filing UUID
- ca27af9d-d7c2-4212-8a7f-733e9972439d
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to coverage of pharmacogenomics under TRICARE, Medicare and Veterans Health Administration
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.